Soleus Capital Issues Letter to The Board of Theratechnologies
Soleus Capital Management, L.P. (“Soleus Capital”), a healthcare investment firm which owns in excess of 10% of the stock of Theratechnologies Inc. (
NASDAQ: THTX) (the “Company”), today sent a letter to the Board of Directors of the Company.
